Insider Selling: Hinge Health (NYSE:HNGE) Chairman Sells $5,018,373.48 in Stock

Hinge Health Inc. (NYSE:HNGE) Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $60.22, for a total transaction of $5,018,373.48. Following the completion of the transaction, the chairman owned 83,334 shares of the company’s stock, valued at $5,018,373.48. This represents a 50.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Gabriel M.I. Mecklenburg also recently made the following trade(s):

• On Friday, June 5th, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $65.54, for a total transaction of $3,277,000.00.
• On Tuesday, May 26th, Gabriel M.I. Mecklenburg sold 83,333 shares of Hinge Health stock. The shares were sold at an average price of $53.79, for a total transaction of $4,482,482.07.
• On Wednesday, May 6th, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $55.01, for a total transaction of $2,750,500.00.
• On Tuesday, April 21st, Gabriel M.I. Mecklenburg sold 33,333 shares of Hinge Health stock. The shares were sold at an average price of $45.05, for a total transaction of $1,501,651.65.
• On Wednesday, April 1st, Gabriel M.I. Mecklenburg sold 50,000 shares of Hinge Health stock. The shares were sold at an average price of $38.46, for a total transaction of $1,923,000.00.
• On Friday, March 6th, Gabriel M.I. Mecklenburg sold 166,666 shares of Hinge Health stock. The shares were sold at an average price of $45.32, for a total transaction of $7,553,303.12.

Hinge Health Trading Up 0.8%

NYSE:HNGE opened at $63.48 on Friday. The firm has a 50-day moving average price of $47.93 and a two-hundred day moving average price of $45.31. Hinge Health Inc. has a twelve month low of $30.08 and a twelve month high of $66.55. The company has a market capitalization of $4.91 billion and a P/E ratio of -5.14.

Hinge Health (NYSE:HNGE) last posted its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The firm had revenue of $182.31 million during the quarter. During the same quarter last year, the business posted $1.30 earnings per share. The business’s revenue was up 47.2% compared to the same quarter last year. On average, equities research analysts predict that Hinge Health Inc. will post 1.21 earnings per share for the current year.

Hinge Health News Summary

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Canaccord Genuity raised its price target on Hinge Health to $65 from $63 and reiterated a buy rating, reinforcing a constructive analyst view on the stock. Article Title
• Positive Sentiment: Other recent commentary also stayed upbeat, including technical coverage pointing to a “golden cross,” which can attract momentum investors. Article Title
• Positive Sentiment: Hinge Health’s last earnings report beat estimates, with revenue up 47.2% year over year, supporting the view that the business is still growing rapidly. Article Title
• Neutral Sentiment: One article highlighted Hinge Health as a promising mid-cap healthcare name, but it did not include a new catalyst beyond a generally favorable long-term investment case. Article Title
• Negative Sentiment: Chairman Gabriel M.I. Mecklenburg disclosed another large insider sale of 50,000 shares at $65.54, adding to a series of recent sales and potentially creating some overhang for sentiment. Article Title

Institutional Investors Weigh In On Hinge Health

Several hedge funds have recently modified their holdings of the stock. California State Teachers Retirement System boosted its position in shares of Hinge Health by 35.2% in the first quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after acquiring an additional 4,986 shares during the last quarter. Estuary Capital Management LP acquired a new stake in shares of Hinge Health in the first quarter worth approximately $15,201,000. Lazard Asset Management LLC boosted its position in shares of Hinge Health by 0.6% in the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock worth $2,456,000 after acquiring an additional 386 shares during the last quarter. Entropy Technologies LP boosted its position in shares of Hinge Health by 28.1% in the first quarter. Entropy Technologies LP now owns 11,749 shares of the company’s stock worth $453,000 after acquiring an additional 2,579 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of Hinge Health by 225.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company’s stock worth $44,852,000 after acquiring an additional 806,007 shares during the last quarter.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the stock. Needham & Company LLC raised their target price on shares of Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Barclays raised their price target on shares of Hinge Health from $52.00 to $62.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Evercore reaffirmed an “outperform” rating and set a $45.00 price target on shares of Hinge Health in a research note on Wednesday, April 8th. Stifel Nicolaus raised their price target on shares of Hinge Health from $59.00 to $67.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company raised their price target on shares of Hinge Health from $68.00 to $80.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $67.53.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.